In focus · trending topic

#IRP #IMUN #HOTSTOCKS

2 stories · following the connections

Immune Therapeutics Announces Special Investor Conference Call to Discuss 2017 Outlook

By Nasdaq OMXJan 27, 2017, 8:40 PM UTC

Immune Therapeutics Retains Investor Relations Partners to Support Company’s Strategic IR Program as it Prepares for Commercialziation

By Nasdaq OMXJan 26, 2017, 3:16 PM UTC